Biogen (BIIB) Receivables (2009 - 2026)
Biogen (BIIB) reported Receivables of $2.91 billion for Q2 2026, up 39.7% from $2.08 billion a year earlier and up 62.6% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Biogen posted Receivables of $1.34 billion, down 4.4% from FY2024.
- Receivables has declined for five consecutive years, with a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
- By year, Receivables came in at $1.4 billion in FY2024 (-15.6%), $1.66 billion in FY2023 (-2.5%), $1.71 billion in FY2022 (-7.4%) and $1.84 billion in FY2021 (-11.0%).
- The Q2 2026 figure ranks as the highest quarterly Receivables in data going back to Q2 2009.
- Year over year, Receivables gained in two of the last eight quarters, with an average decline of 12.8%.
- The high point for year-over-year Receivables in five years was Q2 2026 (growth of 39.7%); the low point was Q4 2025 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.79 billion (Q1 2026), $4.4 million (Q4 2025) and $1.85 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Biogen | 33.37 Bn | 20.03 Bn | 1.96 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.91 Bn |
| Mar 31, 2026 | 1.79 Bn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 1.85 Bn |
| Jun 30, 2025 | 2.08 Bn |
| Mar 31, 2025 | 2.00 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 1.99 Bn |
| Jun 30, 2024 | 2.08 Bn |
| Mar 31, 2024 | 2.00 Bn |
| Dec 31, 2023 | 1.66 Bn |
| Sep 30, 2023 | 2.21 Bn |
| Jun 30, 2023 | 2.12 Bn |
| Mar 31, 2023 | 1.64 Bn |
| Dec 31, 2022 | 1.71 Bn |
| Sep 30, 2022 | 1.68 Bn |
| Jun 30, 2022 | 1.82 Bn |
| Mar 31, 2022 | 2.04 Bn |
| Dec 31, 2021 | 1.84 Bn |
| Sep 30, 2021 | 1.72 Bn |
API Access
Biogen Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();